Post-COVID-19 consultation at Raúl Gómez García Community Hospital during August-October 2021
Keywords:
post-COVID-19 syndrome, post-COVID-19 consultation, COVID-19.Abstract
Introduction: According to the World Health Organization, the post-COVID-19 condition occurs in individuals with a history of probable or confirmed infection by SARS-CoV-2. In Cuba, the care program for recovered patients is evident in the post-COVID-19 consultation.
Objective: To describe the post-COVID-19 consultation at Raúl Gómez García Community Hospital from August to October 2021.
Methods: A descriptive, cross-sectional and retrospective study was carried out of the post-COVID-19 consultation at Raúl Gómez García Community Hospital, in Diez de Octubre municipality, from August to October 2021.
Results: A total of 364 adult patients were seen during the study period. Two hundred seventeen (217) of them were female and 147 male, representing 60% and 40%, respectively; patients in the age range between 40 and 59 years predominated. Among the reasons for referral of patients from the different levels of the health system, anxiety and fear prevailed in 162 cases, representing 44.5% of the total. Most of the patients required rehabilitation and dietary hygienic treatment in 70.8% (258).
Conclusions: The work contributes to the knowledge of the repercussion of this disease in the short and medium term on the health of individuals, and it allows us to observe that even patients with mild and moderate symptoms show sequelae of the disease after the clinical and epidemiological discharge. Follow-up in consultation guarantees the social reintegration of patients in optimal functional conditions.
Downloads
References
1. MINSAP. Protocolo de Actuación Nacional para la COVID-19. Versión 1.6. La Habana: MINSAP; 2021.
2. Zhou W. The coronavirus prevention handbook. 1ed. New York: Skypehorse publishing; 2020 [acceso 27/02/2020]. Disponible en: https://www.moreno-web.net/wordpress/wp-content/uploads/2020/03/Wang_Zhou_Nanshan_Zhong_Qiang_Wang_KeHu_ZaiqiZhang-Coronavirus_PreventionHandbook_101_Science-Based_Tips_That_Could_Save_Your_Life-Skyhorse.pdf
3. WHO. Coronavirus disease COVID-19 Dashboard; 2022 [acceso 02/02/2022]. Disponible en: https://covid19.who.int/
4. SEDISA. Documento para la atención integral al paciente pos-COVID. Fundación Astra Zeneca; 2020 [acceso 15/02/2021]. Disponible en: http://www.sepsiq.org/file/InformacionSM/2020-Sedisa-DocumentoAtencionIntegralPost-Covid.pdf
5. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 New England. Journal of Medicine. 2020;382:727-33. DOI: https://doi.org/10.1056/NEJMoa2001017
6. Nath A. Neurologic complications of coronavirus infections. Neurology. 2020;94:809-10. DOI: https://doi.org/10.1212/WNL.0000000000009455
7. Swanson PA, McGavern DB. Viral diseases of the central nervous system. Curr Opin Virol. 2015;11:44-54. DOI: https://doi.org/10.1016/j.coviro.2014.12.009
8. Avula A, Nalleballe K, Narula N, Sapozhnikovc S, Dandub V, Toom S, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020;87:115-9. DOI: https://doi.org/10.1016/j.bbi.2020.04.077
9. Al Saiegh F, Ghosh R, Leibold A, Avery MB, Schmidt RF, Theofanis T, et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry. 2020;91(8):846-8. DOI: https://doi.org/10.1136/jnnp-2020-323522
10. Infomed. OMS define como enfermedad la pos-COVID-19 o COVID-19 de larga duración. La Habana: Infomed; 2021 [acceso 09/10/2021]. Disponible en: https://instituciones.sld.cu/estomatologiascu/2021/10/09/oms-define-como-enfermedad-la-pos-covid-19-o-covid-19-de-larga-duracion/
11. Diario Pontevedra. Un 3 % de nuevas consultas de neurología son por síndrome pos-COVID; 2021 [acceso 24/11/2021]. Disponible en: https://www.sen.es/saladeprensa/pdf/dossier/noviembre2021/sen6.pdf
12. Granma. ¿Qué es la COVID de larga duración o síndrome pos-COVID? 2022 [acceso 14/01/2022]. Disponible en: https://www.granma.cu/cuba-covid-19/2021-09-05/que-es-la-covid-de-larga-duracion-o-sindrome-poscovid-05-09-20
13. Fernández-de-las-Peñas C, Martín-Guerrero JD, Pellicer-Valero ÓJ, Navarro-Pardo E, Gómez-Mayordomo V, Cuadrado ML, et al. Female Sex is a Risk Factor Associated with Long-TermPost-COVID Related-Symptoms but not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J. Clin. Med. 2022;11(2):413. DOI: https://doi.org/10.3390/jcm11020413
14. Office for National Statistics (ONS). The prevalence of long COVID symptoms and COVID-19 complications; 2021 [acceso 30/04/2021]. Disponible en: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications
15. Office for National Statistics (ONS). Coronavirus (COVID-19). Infection Survey, UK Statistical bulletins; 2021 [acceso 30/04/2021]. Disponible en: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/previousReleases
16. National Institute for Health Research (NIHR). Living with COVID-second review; 2021 [acceso 04/05/2021] Disponible en: https://evidence.nihr.ac.uk/themedreview/living-with-covid19-second-review/
17. Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021 [acceso 11/11/2020];174:576-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33175566/
18. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv [Preprint]. 2021. DOI: https://doi.org/10.1101/2021.01.27.21250617
19. Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. medRxiv [Preprint]. 2021. DOI: https://doi.org/10.1101/2020.12.24.20248802v2.full.pdf
20. Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021 [acceso 06/04/2021];8:416-27. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33836148/
21. Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. IVY Network Investigators; CDC COVID-19 Response Team. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network: United States. MMWR Morb Mortal Wkly Rep. 2020 [acceso 25/06/2020];69(30):993-8. Disponible en: https://jhu.pure.elsevier.com/en/publications/symptom-duration-and-risk-factors-for-delayed-return-to-usual-hea
22. Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with non-critical COVID-19 two months after symptoms’ onset. Clin Microbiol Infect. 2021 [acceso 05/10/2020];27(2):258-63. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33031948/
23. Townsend L, Dowds J, O’Brien K, Sheill G, Dyer AH, O’Kelly B, et al. Persistent poor health post-COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc. 2021 [acceso 21/09/2020];18(6):997-1003. Disponible en: https://www.atsjournals.org/doi/10.1513/AnnalsATS.202009-1175OC
24. Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020 [acceso 25/08/2020];81(6):e4-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32853602/
25. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021 [acceso 30/07/2020];93(2):1013-22. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32729939/
26. D’Cruz RF, Waller MD, Perrin F, Periselneris J, Norton S, Smith LJ, et al. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res. 2021 [acceso 08/02/2021];7(1):00655-2020. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33575312/
27. Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020 [acceso 11/08/2020];324(6):603-5. Disponible en: https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/covidwho-862783
28. Venturelli S, Benatti SV, Casati M, Binda F, Zuglian G, Imeri G, et al. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect. 2021 [acceso 19/01/2021];149:e32. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33461632/
29. Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021 [acceso 23/09/2020];27(1):89-95. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510771/
30. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021 [acceso 22/03/2021];27(4):601-15. Disponible en: https://www.nature.com/articles/s41591-021-01283-z
Download
